474 related articles for article (PubMed ID: 16329645)
1. Cytokine targeting in psoriasis and psoriatic arthritis: beyond TNFalpha.
MclInnes IB
Ernst Schering Res Found Workshop; 2006; (56):29-44. PubMed ID: 16329645
[TBL] [Abstract][Full Text] [Related]
2. Immune regulation in psoriasis and psoriatic arthritis--recent developments.
Hueber AJ; McInnes IB
Immunol Lett; 2007 Dec; 114(2):59-65. PubMed ID: 17928070
[TBL] [Abstract][Full Text] [Related]
3. Early effects of tumour necrosis factor alpha blockade on skin and synovial tissue in patients with active psoriasis and psoriatic arthritis.
Goedkoop AY; Kraan MC; Teunissen MB; Picavet DI; de Rie MA; Bos JD; Tak PP
Ann Rheum Dis; 2004 Jul; 63(7):769-73. PubMed ID: 15194570
[TBL] [Abstract][Full Text] [Related]
4. Long pentraxin 3: a marker of inflammation in untreated psoriatic patients.
Bevelacqua V; Libra M; Mazzarino MC; Gangemi P; Nicotra G; Curatolo S; Massimino D; Plumari A; Merito P; Valente G; Stivala F; La Greca S; Malaponte G
Int J Mol Med; 2006 Sep; 18(3):415-23. PubMed ID: 16865225
[TBL] [Abstract][Full Text] [Related]
5. Immunopathology of psoriasis and psoriatic arthritis.
Veale DJ; Ritchlin C; FitzGerald O
Ann Rheum Dis; 2005 Mar; 64 Suppl 2(Suppl 2):ii26-9. PubMed ID: 15708930
[TBL] [Abstract][Full Text] [Related]
6. Prospective new biologic therapies for psoriasis and psoriatic arthritis.
Mortel MR; Emer J
J Drugs Dermatol; 2010 Aug; 9(8):947-58. PubMed ID: 20684145
[TBL] [Abstract][Full Text] [Related]
7. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
Channual J; Wu JJ; Dann FJ
Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
[TBL] [Abstract][Full Text] [Related]
8. Three decades of psoriasis research: where has it led us?
Sabat R; Sterry W; Philipp S; Wolk K
Clin Dermatol; 2007; 25(6):504-9. PubMed ID: 18021885
[TBL] [Abstract][Full Text] [Related]
9. Cytokines and anticytokines in psoriasis.
Pietrzak AT; Zalewska A; Chodorowska G; Krasowska D; Michalak-Stoma A; Nockowski P; Osemlak P; Paszkowski T; Roliński JM
Clin Chim Acta; 2008 Aug; 394(1-2):7-21. PubMed ID: 18445484
[TBL] [Abstract][Full Text] [Related]
10. New biologics for psoriasis and psoriatic arthritis.
Rozenblit M; Lebwohl M
Dermatol Ther; 2009; 22(1):56-60. PubMed ID: 19222517
[TBL] [Abstract][Full Text] [Related]
11. Immunopathogenesis of psoriasis and pharmacological perspectives.
Loffredo S; Ayala F; Marone G; Delfino G; Stranges S; Marone G
J Rheumatol Suppl; 2009 Aug; 83():9-11. PubMed ID: 19661527
[TBL] [Abstract][Full Text] [Related]
12. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
13. Psoriatic disease--from skin to bone.
Ritchlin C
Nat Clin Pract Rheumatol; 2007 Dec; 3(12):698-706. PubMed ID: 18037929
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-15: a new cytokine target for the treatment of inflammatory diseases.
McInnes IB; Gracie JA
Curr Opin Pharmacol; 2004 Aug; 4(4):392-7. PubMed ID: 15251134
[TBL] [Abstract][Full Text] [Related]
15. Neutralizing IL-21 and IL-15 inhibits pro-inflammatory cytokine production in rheumatoid arthritis.
Andersson AK; Feldmann M; Brennan FM
Scand J Immunol; 2008 Jul; 68(1):103-11. PubMed ID: 18482208
[TBL] [Abstract][Full Text] [Related]
16. Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
Vandooren B; Noordenbos T; Ambarus C; Krausz S; Cantaert T; Yeremenko N; Boumans M; Lutter R; Tak PP; Baeten D
Arthritis Rheum; 2009 Apr; 60(4):966-75. PubMed ID: 19333931
[TBL] [Abstract][Full Text] [Related]
17. Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives.
Loffredo S; Ayala F; Marone GC; Genovese A; Marone G
Reumatismo; 2007; 59 Suppl 1():28-39. PubMed ID: 17828356
[TBL] [Abstract][Full Text] [Related]
18. The role of heparin-binding EGF-like growth factor and amphiregulin in the epidermal proliferation of psoriasis in cooperation with TNFalpha.
Yoshida A; Kanno H; Watabe D; Akasaka T; Sawai T
Arch Dermatol Res; 2008 Jan; 300(1):37-45. PubMed ID: 17960400
[TBL] [Abstract][Full Text] [Related]
19. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
20. Chronic inflammation in psoriasis and obesity: implications for therapy.
Hamminga EA; van der Lely AJ; Neumann HA; Thio HB
Med Hypotheses; 2006; 67(4):768-73. PubMed ID: 16781085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
